EU HTA Regulation Implementation · July 16, 2026

EU HTA Regulation: JCA reports and procedural guidance

Original title: JCA reports

Compilation of Joint Clinical Assessment reports, procedural guidance on AI use in HTA dossiers, data transparency principles, and methodological FAQs for medical devices and IVDs.

High impact Market Access & Reimbursement Medical Devices & IVD Digital Health & AI EU-wide Health technology assessmentAI governanceIn vitro diagnosticsMedical devices

General Principles on the use of Artificial Intelligence in the preparation of the JCA dossier Procedural Guidance for Joint Scientific Consultations (JSC) on Medical Devices (MD) and In Vitro Diagnostic Medical Devices (IVD) Joint Clinical Assessment report on tarlatamab (Imdylltra ) Joint Clinical Assessment report on lurbinectedin(Zepzelca) JCA report on Ojemda (tovorafenib) Guiding Principles on Data Transparency HTACG HTA FAQ publication of JCA report Questions and Answers on general methodological and procedural issues for joint clinical assessments Report on Emerging Health Technologies 2026 Work Programme - Member State Coordination Group on HTA (HTACG)

Read the official source ↗

Published by EU HTA Regulation Implementation. HealthSignal links to the original document; the summary above is extracted from the source text.